Crossing the Same River Multiple Times

ABSTRACT

Every year, the editors of Pharmaceutical Technology Europe conduct a survey (1) designed to measure the state of the bio/pharma industry. The editors selected several intriguing areas of opportunities for participants to choose between, and as shown in Figure 8, just under half (47.3%) chose cell and gene therapies. In addition to cell and gene therapies, machine learning and artificial intelligence (22.3%) also drew significant interest from the survey population.